Frailty in HIV linked to inflammation, bone health, T-cell exhaustion

• by Olivia Anderson

• September 8, 2026

Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial

An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.

• by Teraya Smith

• July 23, 2026

• 3 min

Enterovirus diversity may limit treatment advances

Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.

• by Andrea Surnit

• September 8, 2026

• 4 min

HHS Successfully Concludes Hantavirus Response Effort; Monitoring Ends with No Positive U.S. Case

• by Assistant Secretary for Public Affairs (ASPA)

• June 24, 2026